Tumor counterattack--concept and reality.
Igney
F H
FH
Tumor Immunology Program, German Cancer Research Center, Heidelberg, Germany.
Behrens
C K
CK
Krammer
P H
PH
D000818:Animals; D053222:Fas Ligand Protein; D006084:Graft Rejection / Q000517:prevention & control; D006801:Humans; D008562:Membrane Glycoproteins / Q000235:genetics / Q000378:metabolism*; D009368:Neoplasm Transplantation; D009369:Neoplasms / Q000276:immunology*; D009504:Neutrophils / Q000276:immunology; D015398:Signal Transduction; D014162:Transfection; D019014:fas Receptor / Q000378:metabolism*
C505661:FASLG protein, human; D053222:Fas Ligand Protein; D008562:Membrane Glycoproteins; D019014:fas Receptor